Assessment of Utilization and Pharmacovigilance Based on Spontaneous Adverse Event Reporting of Gadopentetate Dimeglumine as a Magnetic Resonance Contrast Agent After 45 Million Administrations and 15 Years of Clinical Use
2006 ◽
Vol 41
(6)
◽
pp. 491-499
◽
2006 ◽
Vol 157
(2)
◽
pp. 238-245
◽
1993 ◽
Vol 28
(1)
◽
pp. 26-32
◽
2014 ◽
Vol 31
(9)
◽
pp. 976-984
◽
2007 ◽
Vol 120
(1)
◽
pp. 50-55
◽
2017 ◽
Vol 52
(2)
◽
pp. 128-133
◽
1989 ◽
Vol 16
(6)
◽
pp. 561-567
◽
1992 ◽
Vol 27
(6)
◽
pp. 450-455
◽